An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischémie injury

American Journal of Physiology

Volumn 271, Issue 5 PART 2, 1996, Pages

  Kelly, K J ^a   Tolkoff Rubin, Nina E ^b   Rubin, Robert H ^a   Williams Jr , Winfred W ^b   Meehan, Shane M ^c   Meschter, Carol L ^b   Christenson, James G ^a   Bonventre, Joseph V ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; RO 24 4736; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; ENZYME ACTIVITY; HISTOLOGY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY NECROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTECTION; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERCELLULAR ADHESION MOLECULE-1; ISCHEMIA; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; PEROXIDASE; PHENANTHRIDINES; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; REPERFUSION; TRIAZINES;

EID: 0029853672     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Alloatti, G., G. Montrucchio, and G. Camussi. Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction. J. Pharmacol. Exp. Ther. 269: 766-771,1994.
2. Anastasi, E. M., T. H. Williams, G. J. Sasso, D. Chang, D. J. Liberate, and A. C. Loh. Disposition and metabolism of Ro 24-4736 in the rat. Life Sei. 54:483-490,1994.
3. Arnould, T., C. Michiels, and J. Remacle. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CDllb,andICAM-l.Am. J.Physiol. 264(CellPhysiol. 33): C1102-C1110,1993.
4. Badr, K. F., D. K. DeBoer, K. Takahashi, R. C. Harris, A. Fogo, and H. R. Jacobson. Glomerular responses to plateletactivating factor in the rat: role of thromboxane A2. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): P35-F43, 1989.
5. Berti, F., F. Magni, G. Rossoni, L. DeAngelis, and G. Galli. Production and biologic interactions of prostacyclin and plateletactivating factor in acute myocardial ischemia in the perfused rabbit heart. J. Cardiovasc. Pharmacol. 16: 727-732,1990.
6. Bienvenu, K., J. Russell, and D. N. Granger. Plateletactivating factor promotes shear rate-dependent leukocyte adhesion in postcapillary venules. J. Lipid Med. 8: 95-103,1993.
7. Bonventre, J. V. Mechanisms of ischémie acute renal failure. Kidney Int. 43:1160-1178,1993.
8. Bussolino, F., and G. Camussi. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Ear. J. Biochem. 229: 327-337,1995.
9. Butterly, D. W., R. F. Spurney, P. Ruiz, E. Pirotzky, P. Braquet, and T. M. Cofftnan. Role of platelet activating factor in kidney transplant rejection in the rat. Kidney Int. 48: 337343,1995.
10. Crowley, H. J., B. Yaremko, W. M. Selig, D. R. Janero, C. Burghardt, A. F. Welton, and M. O'Donnell. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736. J. Pharmacol. Exp. Ther. 259: 78-85,1991.
11. Filep, J., P. Braquet, and T. Mozes. Significance of plateletactivating factor in mesenteric ischemia-reperfusion. Lipids 26: 1336-1339,1991.
12. Hallenbeck, J. M., A. J. Dutka, T. Tanishima, P. M. Kochanek, K. K. Kumaroo, C. B. Thompson, T. P. Obrenovitch, and T. J. Contreras. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 17: 246-253,1986.
13. Hellberg, P. O. A., and O. K. Kallskog. Neutrophil-mediated post-ischemic tubular leakage in the rat kidney. Kidney Int. 36: 555-561,1989.
14. Henson, P. M., P. J. Barnes, and S. P. Banks-Schlegel. NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. Am. Rev. Respir. Dis. 145: 726-731,1992.
15. Hofer, R. E., T. J. Christopherson, B. W. Scheithauer, J. H. Milde, and W. L. Lanier. The effect of a platelet activating factor antagonist (BN 52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia. Anesthesiology 79: 347-353,1993.
16. Juncos, L. A., Y. L. Ren, S. Arima, and S. Ito. Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. J. Clin. Invest. 91:1374-1379,1993.
17. Kawata, H., K. Sawatari, and J. E. Mayer, Evidence for the role of neutrophils in reperfusion injury after cold cardioplegic ischemia in neonatal lambs. J. Thorac. Cardiovasc. Surg. 103: 908-917,1992.
18. Kelly, K. J., W. W. Williams, R. B. Colvin, and J. V. Bonventre. Antibody to intercellular adhesion molecule-1 protects the kidney against ischémie injury. Proc. Natl. Acad. Sei. USA 91: 812-816,1994.
19. Kelly, K. J., W. W. Williams, R. B. Colvin, S. M. Meehan, T. A. Springer, J. C. Gutierrez-Ramos, and J. V. Bonventre. Intercellular adhesion molecule-1 deficient mice are protected against renal ischemia. J. Clin. Invest. 97:1056-1063,1996.
20. Komatsu, H., A. Koo, E. Ghadishah, H. Zeng, J. F. Kuhlenkamp, M. Inoue, P. H. Guth, and N. Kaplowitz. Neutrophil accumulation in ischémie reperfused rat liver: evidence for a role for Superoxide free radicals. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25): G669-G676,1992.
21. Kubes, P., G. Ibbotson, J. Russell, J. L. Wallace, and D. N. Granger, Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am. J. Physiol. 259 (Gastrointest. Liver Physiol. 22): G300-G305,1990.
22. Leong, L. L., M. J. Sturm, J. M. Papadimitriou, C. J. Stephens, and R. R. Taylor. The effect of a PAF antagonist on ischémie myocardial damage and arrhythmia in the dog. J. Mol. Cell. Cardiol. 24: 641-649,1992.
23. Linas, S. L., D. Whittenburg, P. E. Parsons, and J. E. Repine, Ischemia increases neutrophil retention and worsens acute renal failure: role of oxygen metabolites and 1C AM 1. Kidney Int. 48: 1584-1591, 1995.
24. Linas, S. L., D. Whittenburg, P. E. Parsons, and J. E. Repine. Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int. 42: 610-616,1992.
25. Lopez-Farre, A., M. Torralbo, and J. M. Lopez-Novoa. Glomeruli from ischémie rat kidneys produce increased amounts of platelet activating factor. Biochem. Biophys. Res. Commun. 152:129-135.
26. Mason, J., J. Welsch, and J. Torhorst. The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Int. 31: 65-71,1987.
27. Ontell, S. J., L. Makowka, P. Boccagni, and T. E. Starzl. The role of PAF and its antagonism in transplantation: organ ischemia and preservation. In: Platelet-Activating Factor in Endotoxin and Immune Diseases, edited by D. A. Handley, R. N. Saunders, W. J. Houlihan, and J. C. Tomesch. New York: Dekker, 1990, p. 419-447.
28. Schröder, E., H. Pouleur, W. VanMechelen, A. Keyeux, J. Raigoso, and A. Charlier. Alterations in endocardial vascular resistance after reperfusion in a low flow, high demand model of ischemia: effects of dipyridamole and WEB-2086, a platelet factor antagonist. J. Am. Coll. Cardiol. 16:1750-1759,1990.
29. Suzuki, M., W. Inauen, P. R. Kvietys, M. B. Grisham, C. Meininger, M. E. Schelling, H. J. Granger, and D. N. Granger. Superoxide mediates reperfusion-induced leukocyteendothelial cell interactions. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1740-H1745,1989.
30. Tamatani, T., and M. Miyasaka. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int. Immunol. 2:165-171,1990.
31. Thompson, W. A., S. Coyle, K. VanZee, H. Oldenburg, R. Trousdale, M. Rogy, D. Felsen, L. Moldawer, and S. F. Lowry. The metabolic effects of platelet-activating factor antagonism in endotoxemic man. Arch. Surg. 129: 72-79,1994.
32. Von Asmuth, E. J., and W. A. Buurman. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha induced H2Ü2 release by adherent neutrophil leukocytes. J. Immunol. 154:1383-1390,1995.
33. Wang, J., and M. J. Dünn. Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. Am. J. Physiol. 253 (Renal Fluid Electrolyte Physiol. 22): F1283-F1289, 1987.
34. Yoshikawa, T., S. Takahashi, Y. Naito, S. Ueda, T. Tanigawa, N. Yoshida, and M. Konclo. Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion. Lipids 27:1058-1060,1992.
35. Zhou, W., M. O. McColIum, B. A. Levine, and M. S. Oison. Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology 16:1236-1240,1992.
36. Zimmerman, B. J., J. W. Holt, J. C. Paulson, D. C.Anderson, M. Miyasaka, T. Tamatani, R. F. Todd III, J. R. Rusche, and D. N. Granger. Molecular determinants of lipid mediatorinduced leukocyte adherence and emigration in rat mesenteric venules. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H847H853,1994.